Basic Information
| LncRNA/CircRNA Name | AX800134 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot, RNAi etc. |
| Sample | hepatocellular carcinoma tissues, cell line HepG2, blood |
| Expression Pattern | up-regulated |
| Function Description | In this study, we validated the upregulated expression of AX800134 in HBV-positive HCC compared with HBV-negative HCC. |
| Pubmed ID | 29789998 |
| Year | 2018 |
| Title | The?expression?and?role?of?lncRNA?AX800134?in?hepatitis B virus-related hepatocellular carcinoma |
External Links
| Links for AX800134 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |